Significant Research Initiatives

Piedmont Heart Institute is focused on improving heart and vascular care and outcomes through a strong commitment to research and discovery. With significant research initiatives in place, our team has been able to accomplish:

• #1 ranking in the world for the REPRISE 3 TAVR trial based on volume
• Selected as one of only four sites in the U.S. for the initial trial of a new transcatheter mitral valve therapy
• Selected as one of only five sites in the U.S. for an initial trial of a transcatheter tricuspid valve therapy
• Implanted the first transcatheter mitral valve replacement system in the U.S.

Centers of Excellence Approach to Research

With a Centers of Excellence approach to disease-based research initiatives, we work toward immediate improvements to care with innovative treatment options, stabilization of at risk patients and optimization of quality of life. Piedmont Heart Institute structures our research in the following categories:

• Advanced Heart Failure
• Electrophysiology and Arrhythmia
• General and Preventive Cardiology
• Interventional Cardiology
• Valvular and Structural Heart Disease
• Vascular and Endovascular

Artificial Intelligence Advances in Biotechnology

Working toward research advances across all Centers of Excellence, our team is leading the way with innovative platforms, including artificial intelligence advances in biotechnology. With the ability to accurately predict future disease states, including heart disease and stroke, artificial intelligence is incorporated into all research considerations at Piedmont Heart Institute.